EUVIMEDEUVIMED entdecken
BeobachtungsstudieOpen Access · CC BY-NC-ND 4.0

Application of antithrombotic drugs and risk factor analysis in ICU patients with lower gastrointestinal bleeding from MIMIC-IV

Ding Peng, Huihong Zhai

BMC Gastroenterology · 18.09.2024 · 24 (1)

DOI: 10.1186/s12876-024-03380-y ↗

Kurz gefasst

Beobachtungsstudie in der Zeitschrift BMC Gastroenterology, online erschienen am 18.09.2024. Verfasst von Ding Peng und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology, Xuanwu Hospital Capital Medical University, Beijing, 100053, China. Hauptthemen laut MEDLINE: Gastrointestinal Hemorrhage, Length of Stay, Hospital Mortality, Intensive Care Units. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 15 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

OBJECTIVE: This study aims to assess the effects of antithrombotic therapy on the outcomes of lower gastrointestinal bleeding (LGIB) in ICU patients, focusing on in-hospital mortality, rebleeding, and length of hospital and ICU stays. METHOD: This retrospective observational study utilized the MIMIC-IV 2.2 database, which includes 513 ICU patients with LGIB. RESULT: The in-hospital mortality rate was 7.6%, and the rebleeding rate was 11.1%. The average Oakland risk score among the study population was 22.54. Multivariate Cox regression analysis identified the use of antiplatelet drugs as an independent protective factor for in-hospital mortality (HR = 0.37, 95% CI 0.15-0.90, p = 0.029). Patients on anticoagulants experienced significantly longer hospital stays (13.1 ± 12.2 days vs. 17.4 ± 12.6 days, p = 0.031) compared to those not using these drugs. Propensity score matching also supported these findings, indicating that antithrombotic therapy was associated with lower in-hospital mortality and longer hospital stays even after adjusting for factors like age, gender, and primary diagnosis. CONCLUSIONS: Our analysis using various statistical methods, including propensity score matching and multivariate regression, confirms that use of antithrombotic drugs in 2.3 days, particularly antiplatelets, are associated with a lower risk of in-hospital mortality. However, they may increase the risk of rebleeding and extend hospital stays in certain subgroups.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Gastrointestinal HemorrhageLength of StayHospital MortalityIntensive Care UnitsPlatelet Aggregation InhibitorsHumansMaleFemaleRetrospective StudiesAgedRisk FactorsMiddle AgedRecurrenceAnticoagulantsPropensity ScoreFibrinolytic Agents

Stichwörter der Autor:innen

Antithrombotic drugsLower gastrointestinal bleedingMIMIC

Substanzen

Platelet Aggregation InhibitorsAnticoagulantsFibrinolytic Agents

Autor:innen und Institutionen

  • Department of Gastroenterology, Xuanwu Hospital Capital Medical University, Beijing, 100053, China.
  • Department of Gastroenterology, Xuanwu Hospital Capital Medical University, Beijing, 100053, China. nxykdx1009@163.com.

Zitieren

APA

Peng, D., & Zhai, H. (2024). Application of antithrombotic drugs and risk factor analysis in ICU patients with lower gastrointestinal bleeding from MIMIC-IV. BMC Gastroenterology, 24(1). https://doi.org/10.1186/s12876-024-03380-y

Vancouver

Peng D, Zhai H. Application of antithrombotic drugs and risk factor analysis in ICU patients with lower gastrointestinal bleeding from MIMIC-IV. BMC Gastroenterology. 2024;24(1). doi:10.1186/s12876-024-03380-y

BibTeX
@article{Peng2024,
  author = {Peng, Ding and Zhai, Huihong},
  title = {Application of antithrombotic drugs and risk factor analysis in ICU patients with lower gastrointestinal bleeding from MIMIC-IV},
  journal = {BMC Gastroenterology},
  year = {2024},
  volume = {24},
  number = {1},
  doi = {10.1186/s12876-024-03380-y}
}
Kostenlos starten →